Abstract
Colorectal cancer is the third in mortality and, despite the molecular classifications, between 30% and 40% of patients relapse after chemotherapy, which indicates the need for new therapeutic strategies. There is a growing number of studies using viral vectors for cancer gene therapy, and data from our laboratory has shown that the combined delivery of Arf (tumor suppressor) and interfer…